These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 27531575)

  • 1. Dual Anti-Inflammatory and Anti-Angiogenic Action of miR-15a in Diabetic Retinopathy.
    Wang Q; Navitskaya S; Chakravarthy H; Huang C; Kady N; Lydic TA; Chen YE; Yin KJ; Powell FL; Martin PM; Grant MB; Busik JV
    EBioMedicine; 2016 Sep; 11():138-150. PubMed ID: 27531575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Acid Sphingomyelinase in Shifting the Balance Between Proinflammatory and Reparative Bone Marrow Cells in Diabetic Retinopathy.
    Chakravarthy H; Navitskaya S; O'Reilly S; Gallimore J; Mize H; Beli E; Wang Q; Kady N; Huang C; Blanchard GJ; Grant MB; Busik JV
    Stem Cells; 2016 Apr; 34(4):972-83. PubMed ID: 26676316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulated VEGF and Robo4 correlate with the reduction of miR-15a in the development of diabetic retinopathy.
    Gong Q; Li F; Xie J; Su G
    Endocrine; 2019 Jul; 65(1):35-45. PubMed ID: 30980286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF.
    Sun CY; She XM; Qin Y; Chu ZB; Chen L; Ai LS; Zhang L; Hu Y
    Carcinogenesis; 2013 Feb; 34(2):426-35. PubMed ID: 23104180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-15a/16 inhibits TGF-beta3/VEGF signaling and increases retinal endothelial cell barrier proteins.
    Ye EA; Liu L; Steinle JJ
    Vision Res; 2017 Oct; 139():23-29. PubMed ID: 28774775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-203a-3p inhibits retinal angiogenesis and alleviates proliferative diabetic retinopathy in oxygen-induced retinopathy (OIR) rat model via targeting VEGFA and HIF-1α.
    Han N; Xu H; Yu N; Wu Y; Yu L
    Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):85-94. PubMed ID: 31408201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-dependent cross-talk between VEGF and HIF1α in the diabetic retina.
    Ling S; Birnbaum Y; Nanhwan MK; Thomas B; Bajaj M; Ye Y
    Cell Signal; 2013 Dec; 25(12):2840-7. PubMed ID: 24018047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in acid sphingomyelinase level in human retinal endothelial cells and CD34
    Kady N; Yan Y; Salazar T; Wang Q; Chakravarthy H; Huang C; Beli E; Navitskaya S; Grant M; Busik J
    J Clin Lipidol; 2017; 11(3):694-703. PubMed ID: 28457994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA COL1A2 promotes angiogenesis via regulating miR-29b/VEGF axis in diabetic retinopathy.
    Zou J; Liu KC; Wang WP; Xu Y
    Life Sci; 2020 Sep; 256():117888. PubMed ID: 32497630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of retinal inflammation by rhythmic expression of MiR-146a in diabetic retina.
    Wang Q; Bozack SN; Yan Y; Boulton ME; Grant MB; Busik JV
    Invest Ophthalmol Vis Sci; 2014 May; 55(6):3986-94. PubMed ID: 24867582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-152 represses VEGF and TGFβ1 expressions through post-transcriptional inhibition of (Pro)renin receptor in human retinal endothelial cells.
    Haque R; Hur EH; Farrell AN; Iuvone PM; Howell JC
    Mol Vis; 2015; 21():224-35. PubMed ID: 25802486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-139-5p promotes neovascularization in diabetic retinopathy by regulating the phosphatase and tensin homolog.
    Zhang Z; Song C; Wang T; Sun L; Qin L; Ju J
    Arch Pharm Res; 2021 Feb; 44(2):205-218. PubMed ID: 33609236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic Role of
    Chen Q; Qiu F; Zhou K; Matlock HG; Takahashi Y; Rajala RVS; Yang Y; Moran E; Ma JX
    Diabetes; 2017 Jun; 66(6):1671-1682. PubMed ID: 28270521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The unconventional role of acid sphingomyelinase in regulation of retinal microangiopathy in diabetic human and animal models.
    Opreanu M; Tikhonenko M; Bozack S; Lydic TA; Reid GE; McSorley KM; Sochacki A; Perez GI; Esselman WJ; Kern T; Kolesnick R; Grant MB; Busik JV
    Diabetes; 2011 Sep; 60(9):2370-8. PubMed ID: 21771974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy.
    McArthur K; Feng B; Wu Y; Chen S; Chakrabarti S
    Diabetes; 2011 Apr; 60(4):1314-23. PubMed ID: 21357793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-200-3p suppresses cell proliferation and reduces apoptosis in diabetic retinopathy via blocking the TGF-β2/Smad pathway.
    Xue L; Xiong C; Li J; Ren Y; Zhang L; Jiao K; Chen C; Ding P
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33150936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-15a/16 reduces retinal leukostasis through decreased pro-inflammatory signaling.
    Ye EA; Liu L; Jiang Y; Jan J; Gaddipati S; Suvas S; Steinle JJ
    J Neuroinflammation; 2016 Dec; 13(1):305. PubMed ID: 27931222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-126 contributes to Niaspan treatment induced vascular restoration after diabetic retinopathy.
    Wang Y; Yan H
    Sci Rep; 2016 May; 6():26909. PubMed ID: 27225425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-20b targets AKT3 and modulates vascular endothelial growth factor-mediated changes in diabetic retinopathy.
    Qin B; Liu J; Liu S; Li B; Ren J
    Acta Biochim Biophys Sin (Shanghai); 2016 Aug; 48(8):732-40. PubMed ID: 27421659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular Noncoding RNA HIPK3 Mediates Retinal Vascular Dysfunction in Diabetes Mellitus.
    Shan K; Liu C; Liu BH; Chen X; Dong R; Liu X; Zhang YY; Liu B; Zhang SJ; Wang JJ; Zhang SH; Wu JH; Zhao C; Yan B
    Circulation; 2017 Oct; 136(17):1629-1642. PubMed ID: 28860123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.